Schedule 13D ownership disclosure
Day One Biopharmaceuticals Inc
Security class unavailable · CUSIP: 23954D109
Event date: 2022-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-247006
- Form type
- SC 13D
- Filer
- Canaan XI L.P.
- CIK
- CIK 1712417
- Filed
- Sep 19, 2022
- Reporting period
- Sep 13, 2022
- Description
- Schedule 13D beneficial ownership